Clinical trials
Completed Phase 4 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
469 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 8 |
| 2002 | 12 |
| 2003 | 29 |
| 2004 | 45 |
| 2005 | 38 |
| 2006 | 38 |
| 2007 | 23 |
| 2008 | 40 |
| 2009 | 34 |
| 2010 | 31 |
| 2011 | 22 |
| 2012 | 23 |
| 2013 | 13 |
| 2014 | 13 |
| 2015 | 12 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 8 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 469 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 50 |
| Boehringer Ingelheim | 24 |
| Sanofi | 20 |
| Novartis Pharmaceuticals | 12 |
| Daiichi Sankyo | 11 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 11 |
| Forest Laboratories | 8 |
| University of Florida | 8 |
| Bayer | 6 |
| Yonsei University | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 469 |
| Diabetes Mellitus, Type 2 | 42 |
| Diabetes Mellitus | 35 |
| Cardiovascular Diseases | 20 |
| Dyslipidemias | 16 |
| Essential Hypertension | 15 |
| Obesity | 15 |
| Metabolic Syndrome | 14 |
| Coronary Artery Disease | 13 |
| Insulin Resistance | 13 |
Trials
Showing 1 to 25 of 469. Each trial links to its page on Pharma Observatory.
369 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.